Saturday, May 26, 2012

Expectuss Liquid



carbetapentane citrate, and guaifenesin

Dosage Form: liquid
Expectuss Liquid

Description:


Expectuss Liquid is an alcohol-free, sugar-free, purple liquid for oral administration having a grape odor and flavor.


Each Teaspoon (5 mL) Contains:

CARBETAPENTANE CITRATE 20 mg

GUAIFENESIN 75 mg

CLINICAL PHARMACOLOGY:


Carbetapentane citrate is a centrally acting non-narcotic antitussive.


Guaifenesin is an expectorant. Its action increases the output of respiratory tract fluid by reducing

adhesiveness and surface tension. Sinus and bronchial drainage is improved and dry, nonproductive

coughs become more productive and less frequent.

INDICATIONS AND USAGE:


For temporary relief of non-productive cough accompanying respiratory tract congestion associated with

the common cold, influenza, sinusitis, and bronchitis.

CONTRAINDICATIONS:


Expectuss Liquid is contraindicated in infants, newborns, and in patients with a known

hypersensitivity to any of the components. It is also contraindicated in patients on MAO inhibitor therapy.

WARNINGS:


A persistent cough may be a sign of a serious condition. If cough persists for more than one week

or tends to recur, or is accompanied by fever, rash, or persistent headache, patient reevaluation

should be considered.

PRECAUTIONS: DRUG INTERACTIONS:


Guaifenesin may produce an increase in urinary 5-hydroxy-indoleacetic acid and may therefore interfere

with the interpretation of this test for the diagnosis of carcinoid syndrome. It may also falsely elevate the

 VMA test for catechols. Administration of this drug should be discontinued 48 hours prior to the collection

of urine specimens for such tests.

CARCINOGENESIS, MUTAGENESIS, AND IMPAIRMENT OF FERTILITY:


No adequate and well controlled studies have been conducted to determine whether the components

of Expectuss Liquid have a potential for carcinogenesis, mutagenesis, or impairment of fertility.

PREGNANCY:


Pregnancy Category C: Animal reproduction studies have not yet been conducted with this product.

It is not known whether it can cause fetal harm when administered to a pregnant woman or can affect

reproduction capacity. This product should not be administered to pregnant women.

NURSING MOTHERS:


Due to the possible passage of the ingredients into breast milk, this product should not be given to nursing mothers.

ADVERSE REACTIONS:


Guaifenesin is well tolerated and has a wide margin of safety. Side effects are generally

mild and infrequent. Nausea and vomiting are the most common side effects. Dizziness,

headache, and rash (including urticaria) have been reported rarely.

OVERDOSAGE: SIGNS AND SYMPTOMS:


Incidence of acute toxicity with guaifenesin is low and over dosage is unlikely to produce

serious toxic effects. In laboratory animals no toxicity resulted when guaifenesin was

administered by stomach tube in doses up to 5 grams/kg.


TREATMENT: Treatment of the signs and symptoms of overdosage is symptomatic and

supportive. The patient should be induced to vomit, even if emesis has occurred spontaneously.

Pharmacologic vomiting by the administration of ipecac syrup is a preferred method, however,

vomiting should not be induced in patients with impaired consciousness. Precautions against

aspiration must be taken, especially in infants and children. Following emesis, any drug

remaining in the stomach may be absorbed by activated charcoal administered as a slurry with water.

DOSAGE AND ADMINISTRATION:


Expectuss Liquid is administered orally as follows:


Adults: 1-2 teaspoonfuls every 4-6 hours or as directed by a physician.

Children 6-12 years of age: 1 teaspoonful every 4-6 hours or as directed by a physician.

Children 6 years of age and under: as directed by a physician.



How supplied:


16 fluid ounce bottles NDC# 23359-003-16


KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.

IN CASE OF ACCIDENTAL OVERDOSAGE, CONTACT A POISON CONTROL

CENTER AND SEEK PROFESSIONAL ASSISTANCE IMMEDIATELY.


Store between 59o-86oF (15o-30oC).


DISPENSE IN TIGHT, LIGHT RESISTANT CONTAINERS WITH CHILD RESISTANT CLOSURES

AS DEFINED IN THE USP/NF.


Manufactured for:


Centurion Labs, LLC.

Birmingham, AL 35243


For Professional Use

Consult a Physician


Rev. 7/09

PRODUCT PACKAGING:


The packaging below represents the labeling currently used:


NDC 23359-003-16


Expectuss Liquid


ANTITUSSIVE/EXPECTORANT


Each 5 mL (1 teaspoon) contains:

Carbetapentane Citrate..... 20 mg

Guaifenesin...................... 75 mg


SUGAR FREE

ALCOHOL FREE


Rx Only


1 PINT (473 mL)


CENTURION LABS



Side Panels:


USUAL DOSAGE:


Adults:

1-2 teaspoonfuls every 4 to 6 hours or as directed by a physician.


Children 6-12 years of age:

1 teaspoonful every 4 to 6 hours or as directed by a physician.


Children 2-6 years of age:

1/2 teaspoonful every 4-6 hours or as directed by a physician.


Children under 2 years of age:

Use as directed by a physician.


See package insert for complete prescribing information.


PHARMACIST:

Dispense in a tight, light-resistant container with a child-resistant closure as defined in the USP/NF.


This container is not intended for dispensing to the patient.


DO NOT USE IF FOIL SEAL IS BROKEN OR MISSING!


INDICATIONS AND USAGE:

For temporary relief of non-productive cough accompanying respiratory tract congestion associated

with the common cold, influenza, sinusitis, and bronchitis.


STORAGE:

Store at controlled room temperature, 59o-86oF (15o-30oC).


Keep this and all drugs out of the reach of children.


In case of accidental overdosage, contact a poison control center and seek professional

assistance immediately.


Manufactured For:

Centurion Labs, LLC.

Birmingham, AL 35243


Rev. 07/07










EXPECTUSS  LIQUID
carbetapentane citrate, and guaifenesin  liquid










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)23359-003
Route of AdministrationORALDEA Schedule    











Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Carbetapentane Citrate (Carbetapentane)Carbetapentane Citrate20 mg  in 5 mL
Guaifenesin (Guaifenesin)Guaifenesin75 mg  in 5 mL





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
Color    Score    
ShapeSize
FlavorGRAPEImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
123359-003-16473 mL In 1 BOTTLENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other11/30/2009


Labeler - Centurion Labs, LLC (806756461)
Revised: 12/2009Centurion Labs, LLC




More Expectuss Liquid resources


  • Expectuss Liquid Side Effects (in more detail)
  • Expectuss Liquid Dosage
  • Expectuss Liquid Use in Pregnancy & Breastfeeding
  • Expectuss Liquid Drug Interactions
  • Expectuss Liquid Support Group
  • 0 Reviews for Expectuss - Add your own review/rating


Compare Expectuss Liquid with other medications


  • Cough

No comments:

Post a Comment